| 新型冠状病毒肺炎治疗中的药物不良反应与防治 |
| |
| 引用本文： | 侯静静,龚慧,赵翊畅,徐萍,张毕奎,颜苗.新型冠状病毒肺炎治疗中的药物不良反应与防治[J].药学进展,2020(2):153-158. |
| |
| 作者姓名： | 侯静静 龚慧 赵翊畅 徐萍 张毕奎 颜苗 |
| |
| 作者单位： | 中南大学湘雅二医院药学部;中南大学临床药学研究所;湖南省毒物咨询中心 |
| |
| 摘 要： | 围绕《新型冠状病毒感染的肺炎诊疗方案(试行第六版)》中的治疗试用药物,包括抗病毒药物、糖皮质激素和中药,从各药的作用机制、药物相互作用、药物不良反应等方面,综述新型冠状病毒肺炎(COVID-19)治疗中可能出现的不良反应及防治策略,为临床治疗方案的合理选择提供参考。
|
| 关 键 词： | COVID-19 抗病毒药物 药物不良反应 防治 磷酸氯喹 |
Prevention and Treatment of Adverse Drug Reactions in COVID-19 |
| |
| HOU Jingjing,GONG Hui,ZHAO Yichang,XU Ping,ZHANG Bikui,YAN Miao.Prevention and Treatment of Adverse Drug Reactions in COVID-19[J].Progress in Pharmaceutical Sciences,2020(2):153-158. |
| |
| Authors: | HOU Jingjing GONG Hui ZHAO Yichang XU Ping ZHANG Bikui YAN Miao |
| |
| Institution: | (Department of Pharmacy,the Second Xiangyfa Hospital of Central South University,Changsha 410011,China;Institute of Clinical Pharmacy,Central South University,Changsha 410011,China;Toxicology Counseling Center of Hunan Province,Changsha 410011,China) |
| |
| Abstract: | Based on the medication regimens recommended by Diagnosis and Treatment Scheme for COVID-19(Trial Version 6.0), including antiviral drugs, corticosteroids and traditional Chinese medicines, this article reviews the possible adverse reactions and their prevention and treatment strategy during the treatment of COVID-19 in terms of the mechanisms of action, drug interactions and adverse drug reactions, aiming to provide reference for the selection of reasonable therapeutic regimens. |
| |
| Keywords: | COVID-19 antiviral drug adverse drug reaction prevention and treatment chloroquine phosphate |
| 本文献已被 维普 等数据库收录！ |
|
